Ručilová, V.; Świerczek, A.; Vanda, D.; Funk, P. ; Lemrová, B.; Gawalska, A.; Bucki, A.; Nowak, B.; Zadrożna, M.; Pociecha, K.; Soural, M.; Wyska, E.; Pawłowski, M.; Chłoń-Rzepa, G.; Zajdel, P.
New Imidazopyridines with Phosphodiesterase 4 and 7 Inhibitory Activity and Their Efficacy in Animal Models of Inflammatory and Autoimmune Diseases
Eur. J. Med. Chem. 2021, 209 (-), 112854(1-18). DOI: 10.1016/j.ejmech.2020.112854
Vanda, D.; Canale, V.; Chaumont-Dubel, S.; Kurczab, R.; Satała, G.; Koczurkiewicz, P.; Krawczyk, M.; Pietruś, W.; Blicharz, K.; Pękala, E.; Bojarski, A.; Popik, P.; Marin, P.; Soural, M.; Zajdel, P.
Imidazopyridine-based 5-HT6 receptor neutral antagonists: impact of N1-benzyl and N1-phenylsulfonyl fragments on different receptor conformational state
J. Med. Chem. 2021, 64 (2), 1180-1196. DOI: 10.1021/acs.jmedchem.0c02009
Vanda, D.; Zajdel, P.; Soural, M.
Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases
Eur. J. Med. Chem. 2019, 181 (-), 111569. DOI: 10.1016/j.ejmech.2019.111569
Vanda, D.; Soural, M.; Canale, V.; Chaumont-Dubel, S.; Satała, G.; Kos, T.; Funk, P.; Fülöpová, V.; Lemrová, B.; Koczurkiewicz, P.; Pękala, E.; Bojarski, A.J.; Popik, P.; Marin, P.; Zajdel, P.
Novel non-sulfonamide 5-HT6 receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties
Eur. J. Med. Chem. 2018, 144 (-), 716-729. DOI: 10.1016/j.ejmech.2017.12.053
Lemrová, B.; Smyslová, P.; Popa, I.; Oždian, T.; Zajdel, P.; Soural, M.
Directed Solid-Phase Synthesis of Trisubstituted Imidazo[4,5-c]pyridines and Imidazo[4,5-b]pyridines
ACS Comb. Sci. 2014, 16 (10), 558-565.